dc.contributor.advisor |
Ellenbroek, Bart |
|
dc.contributor.advisor |
Day, Darren |
|
dc.contributor.author |
Chaji, Daniel |
|
dc.date.accessioned |
2020-05-21T04:34:06Z |
|
dc.date.available |
2020-05-21T04:34:06Z |
|
dc.date.copyright |
2020 |
|
dc.date.issued |
2020 |
|
dc.identifier.uri |
http://researcharchive.vuw.ac.nz/handle/10063/8857 |
|
dc.description.abstract |
Knockout of the serotonin reuptake transporter (SERT) in murine animals has been shown to model various neuropsychiatric disorders such as major depressive disorder, autism spectrum disorder, and substance use disorder. Moreover, evidence suggests that abnormalities in glutamatergic synapses at the level of dendritic spines may be involved in the aetiology of these disorders. This thesis investigated the extent to which the SERT knockout model adequately parallels dendritic spine abnormalities associated with these disorders. This investigation focused on an oft-neglected F-actin binding protein highly-localised to dendritic spines, drebrin A, because any changes to dendritic spines would result in changes to drebrin expression, alongside more common markers for assessing synaptic activity, PSD95 and synaptophysin. The frontal cortex was assessed across the three SERT knockout genotypes at a pre-weaning timepoint and at early adulthood. Results indicated a pattern towards reduced expression for drebrin, PSD95 and synaptophysin at the mRNA level, as well as reduced synaptophysin expression at the protein level, at the pre-weaning stage among SERT knockout animals. No synaptic abnormalities were observed at early adulthood. These abnormalities during development were mirrored by a substantial reduction in dendritic spine density on SERT knockout mature cortical neurons in vitro. The recently developed and highly-sensitive in situ hybridization method for assessing mRNA expression in tissue, RNAscope®, was also optimised for drebrin mRNA. Altogether, the results suggested that serotonergic activity influences dendritic spine density and synaptic marker expression insofar as the serotonin system acts as a neuromodulator of the glutamate system, which coincides with the peri- and post- natal development period. These effects seemed to result in aberrations to glutamatergic neurotransmission and dendritic spine activity, which may be contribute to the mechanisms involved in neuropsychiatric disorder pathophysiology. Finally, a model involving activation of the 5-HT2A receptor to partly explain the findings in this thesis, is proposed. |
|
dc.language.iso |
en_NZ |
|
dc.publisher |
Victoria University of Wellington |
en_NZ |
dc.subject |
Serotonin |
en_NZ |
dc.subject |
Serotonin reuptake transporter (SERT) |
en_NZ |
dc.subject |
Neurobiology |
en_NZ |
dc.subject |
Synaptic plasticity |
en_NZ |
dc.subject |
Synapses |
en_NZ |
dc.subject |
Drebrin |
en_NZ |
dc.subject |
Neuropsychiatric disorders |
en_NZ |
dc.subject |
Dendritic spines |
en_NZ |
dc.subject |
Drebrin A |
en_NZ |
dc.subject |
Actin cytoskeleton |
en_NZ |
dc.title |
The role of the serotonin reuptake transporter on cytoskeletal drebrin A expression in dendritic spines: Implications for neuropsychiatric disorders |
en_NZ |
dc.type |
Text |
en_NZ |
vuwschema.contributor.unit |
School of Biological Sciences |
en_NZ |
vuwschema.type.vuw |
Awarded Research Masters Thesis |
en_NZ |
thesis.degree.discipline |
Neuroscience |
en_NZ |
thesis.degree.grantor |
Victoria University of Wellington |
en_NZ |
thesis.degree.level |
Masters |
en_NZ |
thesis.degree.name |
Master of Science |
en_NZ |
dc.rights.license |
Author Retains Copyright |
en_NZ |
dc.date.updated |
2020-05-02T03:28:06Z |
|
vuwschema.subject.anzsrcfor |
060410 Neurogenetics |
en_NZ |
vuwschema.subject.anzsrcfor |
060405 Gene Expression (incl. Microarray and other genome-wide approaches) |
en_NZ |
vuwschema.subject.anzsrcfor |
060103 Cell Development, Proliferation and Death |
en_NZ |
vuwschema.subject.anzsrcfor |
060112 Structural Biology (incl. Macromolecular Modelling) |
en_NZ |
vuwschema.subject.anzsrcfor |
060109 Proteomics and Intermolecular Interactions (excl. Medical Proteomics) |
en_NZ |
vuwschema.subject.anzsrcfor |
060106 Cellular Interactions (incl. Adhesion, Matrix, Cell Wall) |
en_NZ |
vuwschema.subject.anzsrcfor |
110902 Cellular Nervous System |
en_NZ |
vuwschema.subject.anzsrcfor |
110903 Central Nervous System |
en_NZ |
vuwschema.subject.anzsrcfor |
060602 Animal Physiology - Cell |
en_NZ |
vuwschema.subject.anzsrctoa |
1 PURE BASIC RESEARCH |
en_NZ |